88R9626 SHH-D
 
  By: Price H.B. No. 3152
 
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to the identification of the country of manufacture on the
  label for a prescription drug or biological product.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Section 562.006, Occupations Code, is amended by
  adding Subsection (a-1) and amending Subsection (b) to read as
  follows:
         (a-1)  The label on the dispensing container on a drug or
  biological product dispensed by a pharmacy must indicate the
  country where the drug or biological product was manufactured.
         (b)  In addition to the information required by Subsections
  [Subsection] (a) and (a-1), the label on the dispensing container
  of a drug or biological product dispensed by a Class A or Class E
  pharmacy must indicate:
               (1)  the name, address, and telephone number of the
  pharmacy;
               (2)  the date the prescription is dispensed;
               (3)  the name of the prescribing practitioner;
               (4)  the name of the patient or, if the drug or
  biological product was prescribed for an animal, the species of the
  animal and the name of the owner;
               (5)  instructions for use;
               (6)  the quantity dispensed;
               (7)  if the drug or biological product is dispensed in a
  container other than the manufacturer's original container, the
  date after which the prescription should not be used, determined
  according to criteria established by board rule based on standards
  in the United States Pharmacopeia-National Formulary; and
               (8)  any other information required by board rule.
         SECTION 2.  The Texas State Board of Pharmacy shall adopt any
  rules necessary to implement Section 562.006(a-1), Occupations
  Code, as added by this Act, not later than January 1, 2024.
         SECTION 3.  The change in law made by this Act applies only
  to a drug or biological product dispensed on or after March 1, 2024.  
  A drug or biological product dispensed before March 1, 2024, is
  governed by the law in effect immediately before the effective date
  of this Act, and the former law is continued in effect for that
  purpose.
         SECTION 4.  This Act takes effect September 1, 2023.